Pertussis FHA and Pertussis Fimbriae Antibodies
Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
---|---|
Level of Government: | Federal |
Category: |
|
Opps ID: | NBD00159511238825035 |
Posted Date: | Sep 6, 2023 |
Due Date: | Sep 11, 2023 |
Solicitation No: | 77861 |
Source: | https://sam.gov/opp/2bc6d8b22a... |
Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
- Original Published Date: Sep 06, 2023 01:36 pm EDT
- Original Date Offers Due: Sep 11, 2023 12:00 pm EDT
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: Sep 26, 2023
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
-
NAICS Code:
- 325414 - Biological Product (except Diagnostic) Manufacturing
-
Place of Performance:
Atlanta , GA 30333USA
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to BioRad Inc, to obtain Pertussis FHA and Pertussis Fimbriae Antibodies. The MPIR Immunobiology laboratory is working on assay development for the detection of Pertussis antigen. In order to create an antigen detection assay, monoclonal recombinant antibodies need to be obtained. This will be done by using bacterial toxin derived from Bordetella Pertussis and a cell surface protein of Bordetella Pertussis. These two monoclonal recombinant antibodies will be generated through means of HuCAL technology for the purpose of using these antibodies to perform in-vitro research studies. Pertussis FHA and Pertussis Fimbriae antibodies are needed to capture and detect the disease causing pertussis antigen. The Fimbriae monoclonal recombinant antibodies should recognize the bacterial toxin derived from Bordetella Pertussis, and the FHA monoclonal recombinant antibodies should recognize a cell surface protein of the Bordetella pertussis. As additional specification, the antibodies shall not recognize Closely Related Antigens or Cross-Reactive Antigens (CRAs).
This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at Qrz9@cdc.gov by 12:00pm 11 September, 2023.
- 1600 CLIFTON ROAD
- ATLANTA , GA 30333
- USA
- Kourtney Marshall
- qrz9@cdc.gov
- Phone Number 4044984280
- Sep 06, 2023 01:36 pm EDTCombined Synopsis/Solicitation (Original)
- Sep 01, 2023 09:55 am EDT Sources Sought (Original)
TRY FOR FREE
Not a USAOPPS Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.